Physician profile
Michelle Dempsey
NPI 1154622710
$1,223.42
in general payments reported to CMS, 2019-2025
11 companies · $466 in 2025
The $466 reported for 2025 was more than what 90% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.64 · 2021: $23.50 · 2022: $96.09 · 2023: $398 · 2024: $203 · 2025: $466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $988 · Education: $70.00 · Gift: $8.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $988.49 |
| Education | $70.00 |
| Gift | $8.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $440.38 | 2025 | Invisalign |
| Dentsply Sirona INC | $271.47 | 2022-2025 | Primescan Connect, Cerec, Prime&Bond Nt Nano-Technology Light Cured Dental Adhesive |
| Kerr Corporation | $140.88 | 2019-2023 | Endodontics |
| Nobel Biocare USA | $129.15 | 2023 | Nobelactive |
| Septodont INC. | $64.87 | 2022 | |
| Henry Schein, INC. | $62.21 | 2023 | |
| 3m Company | $37.09 | 2019-2021 | |
| Solventum Corporation | $24.36 | 2024 | 3m Filtek, 3m Scotchbond |
| Envista Holdings Corporation | $23.43 | 2024 | Endodontics |
| Voco America INC. | $18.26 | 2022 | |
| Kulzer, LLC | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Dempsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.